Tenaya Therapeutics IncNASDAQ:TNYA
- LAST PRICE4.6600
- TODAY'S CHANGE (%)0.4100 (9.6471%)
- Bid / Lots4.4600/ 1
- Ask / Lots4.6900/ 10
- Open / Previous Close4.2900 / 4.2500
- Day Range
- 52 Week Range
- Volume613,440
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | TNYA |
|---|---|---|
| 09:32 ET | 10587 | 4.29 |
| 09:38 ET | 217 | 4.25 |
| 09:41 ET | 20100 | 4.29 |
| 09:45 ET | 6627 | 4.29 |
| 09:48 ET | 100 | 4.29 |
| 09:50 ET | 80100 | 4.305 |
| 09:52 ET | 14400 | 4.295 |
| 09:54 ET | 5800 | 4.29 |
| 09:56 ET | 100 | 4.295 |
| 10:01 ET | 11300 | 4.2975 |
| 10:08 ET | 200 | 4.295 |
| 10:10 ET | 100 | 4.32 |
| 10:14 ET | 8800 | 4.3 |
| 10:15 ET | 300 | 4.3 |
| 10:19 ET | 524 | 4.26 |
| 10:21 ET | 345 | 4.3 |
| 10:26 ET | 100 | 4.3 |
| 10:28 ET | 100 | 4.3 |
| 10:32 ET | 606 | 4.305 |
| 10:35 ET | 100 | 4.305 |
| 10:37 ET | 100 | 4.305 |
| 10:39 ET | 605 | 4.3223 |
| 10:48 ET | 100 | 4.305 |
| 10:50 ET | 9800 | 4.3 |
| 10:51 ET | 100 | 4.305 |
| 10:53 ET | 10330 | 4.3 |
| 10:55 ET | 100 | 4.31 |
| 10:57 ET | 550 | 4.305 |
| 11:00 ET | 200 | 4.305 |
| 11:02 ET | 3787 | 4.3 |
| 11:04 ET | 8488 | 4.305 |
| 11:06 ET | 2800 | 4.305 |
| 11:08 ET | 200 | 4.3 |
| 11:09 ET | 300 | 4.305 |
| 11:11 ET | 216 | 4.3 |
| 11:13 ET | 300 | 4.305 |
| 11:15 ET | 225 | 4.305 |
| 11:20 ET | 700 | 4.315 |
| 11:22 ET | 120 | 4.315 |
| 11:26 ET | 449 | 4.31 |
| 11:27 ET | 100 | 4.31 |
| 11:29 ET | 1023 | 4.31 |
| 11:31 ET | 100 | 4.31 |
| 11:36 ET | 100 | 4.31 |
| 11:38 ET | 100 | 4.31 |
| 11:40 ET | 900 | 4.3 |
| 11:42 ET | 298 | 4.27 |
| 11:49 ET | 1455 | 4.265 |
| 11:51 ET | 200 | 4.27 |
| 11:56 ET | 100 | 4.28 |
| 11:58 ET | 100 | 4.29 |
| 12:02 ET | 100 | 4.29 |
| 12:07 ET | 3344 | 4.285 |
| 12:12 ET | 700 | 4.285 |
| 12:14 ET | 100 | 4.3 |
| 12:18 ET | 25748 | 4.3 |
| 12:20 ET | 905 | 4.35 |
| 12:21 ET | 200 | 4.37 |
| 12:23 ET | 100 | 4.37 |
| 12:25 ET | 300 | 4.35 |
| 12:27 ET | 280 | 4.37 |
| 12:30 ET | 1143 | 4.38 |
| 12:32 ET | 200 | 4.38 |
| 12:38 ET | 860 | 4.38 |
| 12:39 ET | 4650 | 4.375 |
| 12:43 ET | 3300 | 4.39 |
| 12:45 ET | 200 | 4.39 |
| 12:48 ET | 1200 | 4.375 |
| 12:50 ET | 4076 | 4.38 |
| 12:52 ET | 400 | 4.38 |
| 12:56 ET | 400 | 4.38 |
| 12:57 ET | 300 | 4.38 |
| 12:59 ET | 100 | 4.39 |
| 01:01 ET | 750 | 4.39 |
| 01:03 ET | 600 | 4.39 |
| 01:08 ET | 700 | 4.37 |
| 01:12 ET | 674 | 4.38 |
| 01:14 ET | 2000 | 4.3634 |
| 01:19 ET | 209 | 4.39 |
| 01:26 ET | 25706 | 4.39 |
| 01:28 ET | 15671 | 4.415 |
| 01:30 ET | 4900 | 4.415 |
| 01:32 ET | 7037 | 4.415 |
| 01:33 ET | 3423 | 4.43 |
| 01:35 ET | 658 | 4.45 |
| 01:37 ET | 5600 | 4.4416 |
| 01:39 ET | 100 | 4.45 |
| 01:42 ET | 5000 | 4.45 |
| 01:46 ET | 394 | 4.45 |
| 01:48 ET | 4800 | 4.45 |
| 01:50 ET | 6574 | 4.45 |
| 01:51 ET | 200 | 4.45 |
| 01:53 ET | 300 | 4.45 |
| 01:55 ET | 27457 | 4.385 |
| 01:57 ET | 23420 | 4.395 |
| 02:00 ET | 580 | 4.395 |
| 02:02 ET | 2350 | 4.41 |
| 02:04 ET | 2333 | 4.415 |
| 02:06 ET | 400 | 4.415 |
| 02:08 ET | 1600 | 4.43 |
| 02:09 ET | 1200 | 4.43 |
| 02:11 ET | 346 | 4.42 |
| 02:13 ET | 1613 | 4.44 |
| 02:18 ET | 400 | 4.425 |
| 02:20 ET | 1900 | 4.44 |
| 02:24 ET | 400 | 4.425 |
| 02:26 ET | 400 | 4.425 |
| 02:27 ET | 217 | 4.425 |
| 02:29 ET | 850 | 4.435 |
| 02:31 ET | 2484 | 4.435 |
| 02:33 ET | 100 | 4.45 |
| 02:36 ET | 3714 | 4.45 |
| 02:38 ET | 1670 | 4.475 |
| 02:40 ET | 200 | 4.475 |
| 02:42 ET | 1400 | 4.49 |
| 02:44 ET | 5800 | 4.48 |
| 02:45 ET | 1850 | 4.48 |
| 02:47 ET | 100 | 4.49 |
| 02:49 ET | 200 | 4.48 |
| 02:51 ET | 500 | 4.5 |
| 02:54 ET | 6895 | 4.515 |
| 02:56 ET | 3833 | 4.5 |
| 02:58 ET | 100 | 4.52 |
| 03:00 ET | 500 | 4.5151 |
| 03:02 ET | 1307 | 4.53 |
| 03:03 ET | 3187 | 4.5315 |
| 03:05 ET | 100 | 4.54 |
| 03:07 ET | 3065 | 4.57 |
| 03:09 ET | 1500 | 4.5699 |
| 03:12 ET | 5212 | 4.6 |
| 03:14 ET | 3079 | 4.5964 |
| 03:16 ET | 13148 | 4.555 |
| 03:18 ET | 100 | 4.56 |
| 03:20 ET | 800 | 4.55 |
| 03:21 ET | 1100 | 4.55 |
| 03:23 ET | 1044 | 4.55 |
| 03:25 ET | 1600 | 4.545 |
| 03:27 ET | 3599 | 4.565 |
| 03:30 ET | 667 | 4.56 |
| 03:32 ET | 400 | 4.56 |
| 03:34 ET | 11768 | 4.58 |
| 03:36 ET | 2219 | 4.59 |
| 03:38 ET | 1892 | 4.58 |
| 03:39 ET | 770 | 4.57 |
| 03:41 ET | 1192 | 4.58 |
| 03:43 ET | 23509 | 4.6124 |
| 03:45 ET | 2159 | 4.63 |
| 03:48 ET | 9884 | 4.63 |
| 03:50 ET | 800 | 4.63 |
| 03:52 ET | 1144 | 4.64 |
| 03:54 ET | 3321 | 4.66 |
| 03:56 ET | 4751 | 4.66 |
| 03:57 ET | 2668 | 4.66 |
| 03:59 ET | 28646 | 4.66 |
May 16, 2024
DJ Tenaya Therapeutics Is Maintained at Buy by Canaccord Genuity, from 12:10PM ET on Thursday May 16, 2024 by Dow Jones
12:10PM ET on Thursday May 16, 2024 by Dow Jones
May 15, 2024
DJ Tenaya Therapeutics Price Target Maintained With a $18.00/Share by HC Wainwright & Co., from 12:03PM ET on Wednesday May 15, 2024 by Dow Jones
12:03PM ET on Wednesday May 15, 2024 by Dow Jones
May 14, 2024
DJ Tenaya Therapeutics Cutting Workforce by 22%, from 5:17PM ET on Tuesday May 14, 2024 by Dow Jones
5:17PM ET on Tuesday May 14, 2024 by Dow JonesPress Release: Tenaya Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update, from 4:05PM ET on Tuesday May 14, 2024 by Dow Jones
4:05PM ET on Tuesday May 14, 2024 by Dow JonesTenaya Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update, from 4:05PM ET on Tuesday May 14, 2024 by Dow Jones
4:05PM ET on Tuesday May 14, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Tenaya Therapeutics Inc | 365.9M | -2.8x | --- |
Nautilus Biotechnology Inc | 369.5M | -5.5x | --- |
Fibrobiologics Inc | 371.4M | -12.4x | --- |
Aura Biosciences Inc | 360.2M | -3.9x | --- |
Q32 Bio Inc | 362.6M | -1.2x | --- |
Terns Pharmaceuticals Inc | 381.6M | -4.7x | --- |
Company Information
Tenaya Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. The Company is advancing a pipeline of novel therapies with diverse treatment modalities for rare genetic cardiovascular disorders and more prevalent heart conditions. The Company’s advanced product candidates include TN-201, TN-401, and TN-301. TN-201 is an adeno-associated virus serotype 9 (AAV9)-based gene therapy being developed to treat the underlying cause of MYBPC3 associated HCM by delivering a working MYBPC3 gene to specific cells of the heart via a single infusion. TN-401 is the Company’s adeno-associated virus serotype 9 (AAV9)-based gene therapy being developed for the treatment of arrhythmogenic right ventricular cardiomyopathy (ARVC) due to disease-causing variants in the PKP2 gene. TN-301 is a small molecule for heart failure with preserved ejection fraction.
Contact Information
- Headquarters
- 171 Oyster Point Blvd., Suite 500SOUTH SAN FRANCISCO, CA, United States 94080
- Phone
- 415-865-2066
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- David Goeddel
- Chief Executive Officer, Secretary
- Faraz Ali
- Chief Financial and Business Officer
- Leone Patterson
- Chief Scientific Officer
- Timothy Hoey
- Chief Medical Officer
- Whittemore Tingley
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $365.9M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 78.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.65 |
Book Value | $2.04 |
P/E Ratio | -2.8x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
